Published in Arterioscler Thromb on February 01, 1992
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med (1997) 5.18
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest (1997) 4.18
Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med (2006) 3.65
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1995) 3.54
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A (1997) 2.56
A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest (1998) 2.37
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest (1999) 2.16
T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A (1997) 2.03
Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol (1996) 1.88
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci U S A (2005) 1.82
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest (1996) 1.79
Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest (1994) 1.70
Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis. J Clin Invest (2000) 1.60
Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol (2005) 1.55
Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol (1993) 1.46
Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest (1993) 1.36
Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. J Clin Invest (2002) 1.33
CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am J Pathol (1999) 1.33
Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models. J Am Heart Assoc (2012) 1.29
Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol (1995) 1.27
Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest (1993) 1.19
Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest (1995) 1.18
Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing. FASEB J (2008) 1.17
Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J Clin Invest (1993) 1.16
Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J (1993) 1.09
Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell. Immunology (2003) 1.08
Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. PLoS One (2013) 1.03
Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am J Pathol (2001) 1.00
Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart (1998) 0.96
Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling. J Exp Med (1993) 0.91
Expression of the alpha1beta1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells. J Clin Invest (2003) 0.90
Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect Immun (2001) 0.90
Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis. Arthritis Rheumatol (2016) 0.88
Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins. Mol Med (1999) 0.87
Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature. Front Endocrinol (Lausanne) (2013) 0.87
Atherosclerosis as disease of redox-sensitive genes. Trans Am Clin Climatol Assoc (1998) 0.85
Immunology of atherosclerosis: the promise of mouse models. Am J Pathol (1996) 0.85
Lymphocyte migration into atherosclerotic plaque. Arterioscler Thromb Vasc Biol (2014) 0.85
Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation. J Clin Invest (1994) 0.83
T helper cell polarization in healthy people: implications for cardiovascular disease. J Cardiovasc Transl Res (2013) 0.82
Relationships of differential leukocyte and lymphocyte subpopulations with carotid atherosclerosis in elderly men. J Clin Immunol (2003) 0.82
Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson. Vascul Pharmacol (2011) 0.79
CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis. Circ Res (2016) 0.77
Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitro. Am J Pathol (1993) 0.77
Specific Kv1.3 blockade modulates key cholesterol-metabolism-associated molecules in human macrophages exposed to ox-LDL. J Lipid Res (2012) 0.77
Interleukin-4 Modulation of Platelet-Derived Growth Factor-Induced Smooth Muscle Cell Urokinase Plasminogen Activator. J Thromb Thrombolysis (1998) 0.77
The Jeremiah Metzger Lecture. Pathogenesis of atherosclerosis: redox as a unifying mechanism. Trans Am Clin Climatol Assoc (2003) 0.76
Helper T cells and atherosclerosis: the cytokine web. Postgrad Med J (2005) 0.76
Peripheral Blood Lymphocyte Subsets (CD4+, CD8+ T Cells, NK Cells) in Patients with Cardiovascular and Neurological Complications after Carotid Endarterectomy. Int J Mol Sci (2015) 0.76
Role of Calprotectin as a Modulator of the IL27-Mediated Proinflammatory Effect on Endothelial Cells. Mediators Inflamm (2015) 0.76
Quantification of Various Inflammatory Cells in Advanced Atherosclerotic Plaques. J Clin Diagn Res (2016) 0.75
The immunology of atherosclerosis. Nat Rev Nephrol (2017) 0.75
Plaque Size Is Decreased but M1 Macrophage Polarization and Rupture Related Metalloproteinase Expression Are Maintained after Deleting T-Bet in ApoE Null Mice. PLoS One (2016) 0.75
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis (1986) 5.23
Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol (1989) 3.82
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1995) 3.54
Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis (1999) 3.21
Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation (2000) 3.17
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest (1991) 2.76
Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest (1998) 2.27
Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest (1985) 2.16
EDTA treatment of intermittent claudication--a double-blind, placebo-controlled study. J Intern Med (1992) 1.97
Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res (1988) 1.91
Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol (1996) 1.88
Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest (1992) 1.83
Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest (1998) 1.80
Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol (1986) 1.70
[Anastomotic leakage after low anterior resection for rectal cancer]. Ugeskr Laeger (1997) 1.70
In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation (2001) 1.69
Nuclear factor kappa-B and the heart. J Am Coll Cardiol (2001) 1.68
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation (2001) 1.63
Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res (1992) 1.56
Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg (1995) 1.52
The complexity of allergic patients' IgE repertoire correlates with serum concentration of allergen-specific IgE. Clin Exp Allergy (2012) 1.51
Correlations between clinical variables and gene-expression profiles in carotid plaque instability. Eur J Vasc Endovasc Surg (2011) 1.50
T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci U S A (1991) 1.49
Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet (1988) 1.46
The glucose uptake of human adipose tissue in obesity. Eur J Clin Invest (1971) 1.44
Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension (1994) 1.44
Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy. Clin Exp Allergy (2014) 1.44
Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol (1996) 1.41
Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. Am J Pathol (1991) 1.39
LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 1.39
Reduced frequency of memory CD8+ T lymphocytes in cerebrospinal fluid and blood of patients with multiple sclerosis. Autoimmunity (1995) 1.39
Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci U S A (1988) 1.38
Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis (1999) 1.38
Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest (1991) 1.35
Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31
Skeletal muscle metabolism in patients with malignant tumor. Eur J Cancer (1976) 1.31
Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2000) 1.30
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A (1999) 1.28
Energy metabolism in relation to oxygen partial pressure in human skeletal muscle during exercise. Biochem J (1981) 1.27
Epidural electrical stimulation in severe limb ischemia. Pain relief, increased blood flow, and a possible limb-saving effect. Ann Surg (1985) 1.26
Interferon-gamma inhibits arterial stenosis after injury. Circulation (1991) 1.22
Several extracellular domains of the neural cell adhesion molecule L1 are involved in neurite outgrowth and cell body adhesion. J Neurosci (1993) 1.21
Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab Invest (1989) 1.21
Activation of inducible nitric oxide synthase/nitric oxide by curli fibers leads to a fall in blood pressure during systemic Escherichia coli infection in mice. J Infect Dis (2001) 1.19
Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand J Immunol (2004) 1.19
Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim Biophys Acta (1990) 1.18
Smooth muscle cells express Ia antigens during arterial response to injury. Lab Invest (1988) 1.18
Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand J Immunol (1999) 1.17
Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord (2003) 1.16
Enzyme activities in skeletal muscles from patients with peripheral arterial insufficiency. Eur J Clin Invest (1976) 1.15
Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res (1991) 1.14
Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med (1994) 1.14
Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells. Proc Natl Acad Sci U S A (1984) 1.14
Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis (1990) 1.13
Immunohistochemical localization of lipoprotein lipase in human adipose tissue. Atherosclerosis (1984) 1.12
Autoimmunity in atherosclerosis: a protective response losing control? J Intern Med (2008) 1.12
Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb Haemost (2011) 1.10
Evidence for antigen-driven T-cell response in unstable angina. Circulation (2000) 1.09
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Physical training of patients with intermittent claudication: indications, methods, and results. Surgery (1978) 1.08
[Recurrence and survival after conventional low anterior resection for rectal cancer]. Ugeskr Laeger (2001) 1.07
Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb (1994) 1.07
Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions. Acta Pathol Microbiol Immunol Scand A (1984) 1.07
Identification and analysis of macrophage-derived foam cells from human atherosclerotic lesions by using a "mock" FL3 channel in flow cytometry. Cytometry (1997) 1.07
Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res (1998) 1.06
Immune mechanisms in atherosclerosis. Coron Artery Dis (1994) 1.06
Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res (1996) 1.04
Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol (1989) 1.04
Metabolic activity in human skeletal muscle. Effect of peripheral arterial insufficiency. Eur J Clin Invest (1972) 1.03
Ultrastructural studies on the localization of IgG in the aortic endothelium and subendothelial intima of atherosclerotic and nonatherosclerotic rabbits. Exp Mol Pathol (1980) 1.02
Physical training in man. Skeletal muscle metabolism in relation to muscle morphology and running ability. Eur J Appl Physiol Occup Physiol (1977) 1.01
Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res (1999) 1.01
The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur J Immunol (1999) 1.01
3-Hydroxy-3-methylglutaric aciduria. J Neurogenet (1984) 1.00
Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am J Pathol (2001) 1.00
Reduced folate transport to the CNS in female Rett patients. Neurology (2003) 1.00
Aortic endothelial cell death and replication in normal and lipopolysaccharide-treated rats. Am J Pathol (1985) 1.00
Evidence for cell death in the vascular endothelium in vivo and in vitro. Am J Pathol (1983) 1.00
Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp Cell Res (1988) 0.99
Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol (1993) 0.98
Carbohydrate and lipid metabolism in middle-aged, physically well-trained men. Metabolism (1972) 0.98
Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. Arterioscler Thromb Vasc Biol (1999) 0.96
Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. J Clin Invest (1989) 0.96
Positive and negative effects of anticoagulant treatment during and after arterial embolectomy. J Cardiovasc Surg (Torino) (1978) 0.96
Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol (1995) 0.96
Fc-dependent binding of monocytes to areas with endothelial injury in the rabbit aorta. Exp Mol Pathol (1981) 0.96
Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg (2000) 0.95
The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol (2005) 0.95
Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. Arterioscler Thromb Vasc Biol (1999) 0.95